1. NF-κB
  2. NF-κB
  3. DMAPT

DMAPT (Synonyms: Dimethylamino Parthenolide)

Cat. No.: HY-16172
Handling Instructions

DMAPT (Dimethylamino Parthenolide), a water soluble analogue of Parthenolide (PTL), is an oral active NF-κB inhibitor, with a LD50 of 1.7 μM for cell population in AML cells. Has potential anti-cancer and anti-metastatic effect.

For research use only. We do not sell to patients.

DMAPT Chemical Structure

DMAPT Chemical Structure

CAS No. : 870677-05-7

Size Price Stock
5 mg USD 150 Get quote

* Please select Quantity before adding items.

Customer Review

Top Publications Citing Use of Products

View All NF-κB Isoform Specific Products:

  • Biological Activity

  • Technical Information

  • Purity & Documentation

  • References

Description

DMAPT (Dimethylamino Parthenolide), a water soluble analogue of Parthenolide (PTL), is an oral active NF-κB inhibitor, with a LD50 of 1.7 μM for cell population in AML cells. Has potential anti-cancer and anti-metastatic effect[1].

IC50 & Target

NF-κB[1].

In Vitro

DMAPT treatment decreased constitutive NF-κB binding activity, inhibits cell proliferation and viability of PC-3 and DU145 cells[2].
Treatment of PC-3 and DU145 cells with 5 and 4 μM DMAPT, respectively, increases the population doubling times of PC-3 prostate cancer cells from 23.0 ± 5.0 h to 42.0 ± 3.0 h and of the DU145 cells from 20.4 ± 2.2 h to 72.5 ± 24.8 h[2].

Cell Proliferation Assay[2]

Cell Line: PC-3 and DU145 cells.
Concentration: PC-3 cells (0, 2.5, 5 μM), DU145 cells (0 and 4 μM).
Incubation Time: 24 and 48 hours.
Result: Decreased constitutive NF-κB binding activity, inhibits cell proliferation and viability of PC-3 and DU145 cells.
In Vivo

Treatment with DMAPT (100 mg/kg, Oral gavage daily for 7 days) increases sensitivity of PC-3 tumor xenografts to X-rays[2].
DMAPT (100 mg/kg, Oral gavage thrice weekly from 42 to 300 days since birth) treatment slows normal tumor development in TRAMP mice, extending the time-to-palpable prostate tumor by 20%[3].
DMAPT further reduces the metastatic area below that of the water vehicle treatment group in lung tissues (0.10% ± 0.15 SD, 92% reduction, p = 0.0028) in TRAMP mice[3].

Animal Model: PC-3 tumor xenograft in athymic nude mice[2].
Dosage: 100 mg/kg.
Administration: Oral gavage daily for 7 days.
Result: Increased sensitivity of PC-3 tumor xenografts to X-rays.
Animal Model: Six-week-old male TRAMP mice[3].
Dosage: 100 mg/kg.
Administration: Oral gavage thrice weekly from 42 to 300 days since birth.
Result: Slowed normal tumor development in TRAMP mice, extending the time-to-palpable prostate tumor by 20%.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

References
Molecular Weight

293.40

Formula

C₁₇H₂₇NO₃

CAS No.

870677-05-7

SMILES

C/C1=C/CC[[email protected]]2(C)[[email protected]](O2)[[email protected]]3([H])[[email protected]](CC1)([H])[[email protected]@H](CN(C)C)C(O3)=O

Shipping

Room temperature in continental US; may vary elsewhere

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2

Inquiry Online

Your information is safe with us. * Required Fields.

Product name

 

Salutation

Applicant name *

 

Email address *

Phone number *

 

Organization name *

Country or Region *

 

Requested quantity *

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
DMAPT
Cat. No.:
HY-16172
Quantity:

DMAPT

Cat. No.: HY-16172